Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives

被引：31
|
作者：
Natsuaki, Masahiro [1 ]
Sonoda, Shinjo [1 ]
Yoshioka, Goro [1 ]
Hongo, Hiroshi [1 ]
Kaneko, Tetsuya [1 ]
Kashiyama, Kuninobu [1 ]
Yokoi, Kensuke [1 ]
Hikichi, Yutaka [2 ]
Node, Koichi [1 ]
机构：
[1] Saga Univ Hosp, Dept Cardiovasc Med, 5-1-1 Nabeshima, Saga 8498501, Japan
[2] Saga Med Ctr, Cardiovasc Ctr, Koseikan, Saga, Japan
来源：
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS | 2022年 / 37卷 / 02期
关键词：
Antiplatelet therapy; Antithrombotic therapy; Percutaneous coronary intervention; ELUTING STENT IMPLANTATION; ARTERY-DISEASE; CARDIOVASCULAR EVENTS; ATRIAL-FIBRILLATION; OPTIMAL DURATION; VASCULAR EVENTS; FOCUSED UPDATE; DOUBLE-BLIND; CLOPIDOGREL; ASPIRIN;
D O I：
10.1007/s12928-022-00847-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Antiplatelet therapy after percutaneous coronary intervention (PCI) has been changing in parallel with the development of drug-eluting stents (DES) and antiplatelet agents. The recommendation of dual antiplatelet therapy duration is getting shorter due to the decreased risk of stent thrombosis in new-generation DES, the use of a P2Y(12) inhibitor as a monotherapy, and the increasing prevalence of high bleeding risk patients. Antithrombotic therapy after PCI has also changed due to the introduction of direct oral anticoagulants. Aspirin-free P2Y(12) inhibitor monotherapy is now being evaluated in several prospective studies as a novel strategy of antiplatelet therapy after PCI. This review shows a current status and provides future perspectives for the antiplatelet therapy after PCI.
引用
收藏
页码：255 / 263
页数：9
相关论文
共 50 条
  • [31] Oral triple antiplatelet therapy after percutaneous coronary intervention: Subject with ongoing arguments?
    Amasyali, Basri
    Celik, Turgay
    Iyisoy, Atila
    Kilic, Ayhan
    Isik, Ersoy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (01) : 112 - 113
  • [32] Antiplatelet therapy strategies after percutaneous coronary intervention in patients needing oral anticoagulation
    Saint Etienne, Christophe
    Angoulvant, Denis
    Simeon, Edouard
    Fauchier, Laurent
    FUTURE CARDIOLOGY, 2013, 9 (06) : 759 - 762
  • [33] Adherence to antiplatelet therapy after percutaneous coronary intervention: a population study in a region of Italy
    Pinnarelli, Luigi
    Mayer, Flavia
    Bauleo, Lisa
    Agabiti, Nera
    Kirchmayer, Ursula
    Belleudi, Valeria
    Di Martino, Mirko
    Autore, Camillo
    Ricci, Roberto
    Violini, Roberto
    Fusco, Danilo
    Davoli, Marina
    Perucci, Carlo A.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (03) : 230 - 237
  • [34] Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?
    Giri, Jay
    Nathan, Ashwin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (07) : 635 - 637
  • [35] Platelet Volume Indices are Associated with High Residual Platelet Reactivity after Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Kim, Yun Gi
    Suh, Jung-Won
    Yoon, Chang-Hwan
    Oh, Il-Young
    Cho, Young-Seok
    Youn, Tae-Jin
    Chae, In-Ho
    Choi, Dong-Ju
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (05) : 445 - 453
  • [36] Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Camaj, Anton
    Miller, Michael S.
    Halperin, Jonathan L.
    Giustino, Gennaro
    CARDIOLOGY CLINICS, 2020, 38 (04) : 551 - 561
  • [37] Antiplatelet Therapy and Percutaneous Coronary Interventions
    Davanzo, Rene Hameau
    Alarcon, Alberto Fuensalida
    Calquin, Jorge Quitral
    Varela, Pablo Sepulveda
    Sepulveda, Alejandro Martinez
    Herreros, Ramon Corbalan
    Patel, Sanjay
    Rodriguez, Gonzalo Martinez
    CURRENT CARDIOLOGY REVIEWS, 2021, 17 (03) : 302 - 313
  • [38] Are Shorter Durations of Dual Antiplatelet Therapy Acceptable Following Percutaneous Coronary Intervention?
    Lewis-Gonzalez, Jessica M.
    Nawarskas, James J.
    CARDIOLOGY IN REVIEW, 2018, 26 (04) : 213 - 217
  • [39] Evaluation of the duration of dual-antiplatelet therapy after percutaneous coronary intervention: a retrospective audit on the compliance with guidelines or cardiologist recommendation
    Ho, Wing Man
    Hill, Courtney
    Michael, Hayley
    Winckel, Karl
    JOURNAL OF PHARMACY PRACTICE AND RESEARCH, 2022, 52 (01) : 42 - 48
  • [40] Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trials
    Montalto, Claudio
    Costa, Francesco
    Leonardi, Sergio
    Micari, Antonio
    Oreglia, Jacopo A.
    Vranckx, Pascal
    Capodanno, Davide
    ten Berg, Jurrien
    Lopes, Renato D.
    Valgimigli, Marco
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (03) : 220 - 230
12345